USPTO serial 78528808
ESODEX
Reviewed by CopyMark Law Group
Reg. 3216946Status 710
- Filing date
- Status date
- Registration date
- Mar 13, 2007
- Examiner
- PERRY, KIMBERLY B
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with ESODEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
OXFORDSHIRE, GB
Oxfordshire, GB
Oxfordshire, GB
Oxfordshire, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Purvi J. Patel
Purvi J. Patel Haynes and Boone, LLP2323 Victory Avenue, Suite 700Dallas, TX 75219-7673UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Antibodies, proteins, T cell proteins and peptides for medical use, monoclonal antibodies for clinical or medical use; pharmaceutical and biochemical substances and preparations namely, small molecules, CD80 antagonists for the treatment of cancer and auto-immune diseases; in vivo immunotherapeutic, immunoprophylactic and immunodiagnostic agents, preparations and substances for clinical or medical use; vaccines; protein conjugates for the treatment of cancer and auto-immune diseases; diagnostic and analytical preparations for medical and veterinary use, namely, products that diagnose and analyze the effects of cancer and tissue damage caused by inflammation due to auto-immune diseases; gene therapy and cell therapy products namely, T-cell receptors; enzymes and enzyme preparations for medical purposes for the treatment of cancer and auto-immune diseases for clinical or medical use; chemical products for use in medical science namely, T-cell receptors, small molecules and protein therapeutics for clinical or medical use | SECTION 8 - CANCELLED | — |
| 010 | Apparatus and instruments for diagnostic and therapeutic research namely, instruments for measuring the spread of cancerous tissue, tissue damage or movement into affected limbs or organs; display apparatus namely, multi-well plates and arrays for medical and clinical diagnosis and analysis; surgical and medical apparatus and instruments, namely injectors for medical purposes, medical and surgical syringes, pre-filled vials containing pharmaceuticals and bioceuticals, namely small molecules and protein therapeutics involving T-cell receptors for the treatment of cancer and auto-immune diseases | SECTION 8 - CANCELLED | — |
| 042 | Biotechnology services, research and development in biotechnology namely, product research and development for others in the field of biotechnology; scientific and medical research and development for others in the field of biotechnology and genomics, pharmaceutical drug development services and pharmaceutical product development; genetic engineering services, licensing intellectual property including trademarks and patents in the field of biotechnology | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MEDIGENE LIMITED
- Other trademarks owned by Avidex Limited
- Other trademarks owned by Avidex Limited
- Other trademarks owned by Avidex Limited
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named ESODEX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 18, 2013 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Dec 17, 2008 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 17, 2008 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 19, 2007 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Mar 13, 2007 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 26, 2006 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 6, 2006 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 17, 2006 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Oct 27, 2006 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Sep 15, 2006 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Aug 24, 2006 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 11, 2006 | ALIE | ASSIGNED TO LIE | — |
| Aug 9, 2006 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 27, 2006 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 10, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 10, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 22, 2006 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 22, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 2, 2006 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 10, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 10, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 15, 2005 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 14, 2005 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 13, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 17, 2004 | NWAP | NEW APPLICATION ENTERED | — |